Man­u­fac­tur­ing roundup: As­traZeneca widens part­ner­ship in Abu Dhabi; Mod­er­na fi­nal­izes its part­ner­ship with the UK

UK-based As­traZeneca and Abu Dhabi-based G42 Health­care have inked a strate­gic man­u­fac­tur­ing deal to make drugs in the cap­i­tal of the Unit­ed Arab Emi­rates.

The man­u­fac­tur­ing deal will fo­cus on R&D and “lo­cal­iz­ing” in­dus­tries to pro­duce phar­ma prod­ucts, as As­traZeneca al­so has “on­go­ing ef­forts” with the De­part­ment of Health of Abu Dhabi.

Abu Dhabi has un­veiled plans to dou­ble the size of its man­u­fac­tur­ing sec­tor by 2031, and this deal plays in­to that fore­cast, as both G42 and As­traZeneca col­lab­o­rate to boost ex­ports of drug prod­ucts and col­lab­o­rate on re­search projects.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER